Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Non Operating Income: 2020-2023

Historic Other Non Operating Income for ADC Therapeutics (ADCT) over the last 2 years, with Sep 2023 value amounting to $860,000.

  • ADC Therapeutics' Other Non Operating Income rose 18354.94% to $860,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $1.7 million, marking a year-over-year increase of 3902.65%. This contributed to the annual value of -$25,650 for FY2022, which is 26.49% up from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Other Non Operating Income is $860,000, which was up 3.24% from $833,000 recorded in Q2 2023.
  • ADC Therapeutics' Other Non Operating Income's 5-year high stood at $860,000 during Q3 2023, with a 5-year trough of -$79,261 in Q2 2020.
  • For the 3-year period, ADC Therapeutics' Other Non Operating Income averaged around $204,314, with its median value being -$4,898 (2022).
  • Per our database at Business Quant, ADC Therapeutics' Other Non Operating Income plummeted by 32.88% in 2022 and then soared by 18,354.94% in 2023.
  • Quarterly analysis of 4 years shows ADC Therapeutics' Other Non Operating Income stood at -$79,261 in 2020, then reached -$18,614 in 2021, then crashed by 32.88% to $4,660 in 2022, then surged by 18,354.94% to $860,000 in 2023.
  • Its Other Non Operating Income stands at $860,000 for Q3 2023, versus $833,000 for Q2 2023 and $4,660 for Q3 2022.